ViSalus Appoints PhD To Lead Research & Development
As part of its ongoing commitment to fight the global obesity epidemic, ViSalus, the company known for the Body by Vi™ 90-Day Challenge, today announced the appointment of Dr. Silvia Uribe, PhD., as Vice President, Research & Development.
Dr. Uribe will be responsible for providing strategic direction, planning and leadership for the formulation, licensing and regulatory management of the Company's global product portfolio.
She will report directly to Todd A. Goergen, Chief Strategy Officer of ViSalus.
Silvia's experience developing nutritional products and functional foods for leading global brands is a key asset to ViSalus as we expand our product line in North America and Europe, commented Ryan J. Blair, Chief Executive Officer.
Her leadership will allow us to increase further our internal development capabilities while continuing our partnerships with external developers and suppliers.
Dr. Uribe was most recently Technology Director at Sigma Alimentos. Prior to that she served as the Baking Innovation Center Research and Development Director for PepsiCo Americas Foods. Dr. Uribe also worked for over 13 years at the Kellogg Company in several roles, ending her tenure as Senior Director of Technology Transfer and Intellectual Asset Management.
Dr. Uribe earned her undergraduate degree at National Autonomous University of Mexico and her PhD at University of Leeds in England.
For more information about ViSalus visit vi.com and follow the Vi-Community on Facebook and Twitter.
Founded in 2005 with headquarters in Los Angeles, CA and Troy, MI. ViSalus is the company behind the Body by Vi™ Challenge, a 90-day weight-loss and fitness transformation platform. ViSalus champions personal victories and entrepreneurship through a social marketing model, premium products, and support community. ViSalus is majority-owned by Blyth, Inc. (NYSE: BTH)
Get more information, facts and figures about ViSalus, click here for the ViSalus overview.